Increased expression of adenosine A2A receptors in patients with spontaneous and head-up-tilt-induced syncope

Heart Rhythm

Volumn 4, Issue 7, 2007, Pages 870-876

  Carrega, Louis ^a   Saadjian, Alain Y ^b   Mercier, Laurence ^a   Zouher, Ibrahim ^a   Bergé Lefranc, Jean Louis ^a   Gerolami, Victoria ^a   Giaime, Philippe ^a   Sbragia, Pascal ^b   Paganelli, Franck ^b   Fenouillet, Emmanuel ^c   Lévy, Samuel ^b   Guieu, Régis P ^a,c  

^a TIMONE HOSPITAL   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c CNRS   (France)

Author keywords

Adenosine; Head up tilt test; Receptor; Syncope

Indexed keywords

ADENOSINE; ADENOSINE A2A RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEAD TILTING; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RECEPTOR AFFINITY; RECURRENT DISEASE; SYNCOPE; UPREGULATION;

ADENOSINE; ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; RECEPTOR, ADENOSINE A2A; SYNCOPE;

EID: 34250760447     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2007.03.002     Document Type: Article

References (36)

1. Goldschlager N., Epstein A.E., Grubb B.P., Olshansky B., Prystowsky E., Roberts W.C., Scheinman M.M., Practice Guidelines Subcommittee, and North American Society of Pacing and Electrophysiology. Etiologic considerations in the patient with syncope and an apparently normal heart. Arch Intern Med 163 (2003) 151-162
2. Brignole M. Neurally-mediated syncope. Ital Heart J 6 (2005) 249-255
3. Mosqueda-Garcia R., Furlan R., Tank J., and Fernandez-Violante R. The elusive pathophysiology of neurally mediated syncope. Circulation 102 (2000) 2898-2906
4. Grubb B.P. Neurocardiogenic syncope. N Engl J Med 352 (2005) 1004-1010
5. Boh-Oka S., Ohmori H., Kawabe T., Tutimaya Y., Shimamoto Y., Shioji S., Obana M., Satani O., Wanaka Y., Hamada M., Baba A., Tsuda K., Hano T., and Nishio I. Neurally mediated syncope and cardiac beta-adrenergic receptor function. J Cardiovasc Pharmacol 38 Suppl 1 (2001) S75-S79
6. Saadjian A., Levy S., Franceschi F., Zouher I., Paganelli F., and Guieu R.P. Role of endogenous adenosine as a modulator of syncope induced during tilt testing. Circulation 106 (2002) 569-574
7. Varani K., Laghi-Pasini F., Camurri A., Capecchi P.L., Maccherini M., Diciolla F., Ceccatelli L., Lazzerini P.E., Ulouglu C., Cattabeni F., Borea P.A., and Abbracchio M.P. Changes of peripheral A2A adenosine receptors in chronic failure and cardiac transplantation. FASEB J 17 (2003) 280-282
8. Burnstock G., and Kennedy C. Purinergic receptors in the cardiovascular system. Prog Pharmacol 6 (1986) 111-132
9. Picano E., and Abbracchio M.P. Adenosine, the imperfect endogenous anti-ischemic cardio-neuroprotector. Brain Res Bull 52 (2000) 75-82
10. Baxter G.F. Role of adenosine in delayed preconditioning of myocardium. Cardiovasc Res 55 (2002) 483-494
11. Iwamoto T., Umemura S., Toya Y., Uchibori T., Kogi K., Takagi N., and Ishii M. Identification of adenosine A2 receptor-cAMP system in human aortic endothelial cells. Biochem Biophys Res Commun 199 (1994) 905-910
12. Shryock J.C., and Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology and pharmacology. Am J Cardiol 79 (1997) 2-10
13. Ledent C., Vaugeois J.M., Schiffmann S.N., Pedrazzini T., El Yacoubi M., Vanderhaegen J.J., Costentin J., Heath J.K., Vassart G., and Parmentier M. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the A2A receptor. Nature 388 (1997) 674-678
14. Thomas T., St Lambert J.H., Dashwood M.R., and Spyer K.M. Localization and action of A2A receptors in regions of the brainstem important in cardiovascular control. Neuroscience 95 (2000) 513-518
15. Brignole M., Alboni P., Benditt D., Bergfeldt L., Blanc J.J., Bloch Thomsen P.E., Gert van Dijk J., Fitzpatick A., Hohnloser S., Janousek J., Kapoor W., Kenny R.A., Kulakowski P., Masotti G., Moya A., Raviele A., Sutton R., Theodorakis G., Ungar A., and Wieling W. Guidelines on management (diagnosis and treatment) of syncope-Update 2004. Europace 6 (2004) 467-537
16. Brignole M., Gaggioli G., Menozzi C., Del Rosso A., Costa S., Bartoletti A., Bottoni N., and Lolli G. Clinical features of adenosine sensitive syncope and tilt induced vasovagal syncope. Heart 83 (2000) 24-28
17. Poucher S.M., Keddie J.R., Singh P., Stoggall S.M., Caulkett P.W., Jones G., and Coll M.G. The in vitro pharmacology of ZM 241385, a potent, non xanthine A2A selective adenosine receptor antagonist. Br J Pharmacol 115 (1995) 1096-1102
18. Gonçalves J., and Queiroz G. Purinergic modulation of noradrenaline release in rat tail artery: tonic modulation mediated by inhibitory P2Y and facilitory A2A purinoreceptors. Br J Pharmacol 117 (1996) 156-160
19. Rubino A., Ralevic V., and Burnstock G. The P1 purinoreceptors that mediate the prejunctional inhibitory effect of adenosine on capsaicine-sensitive non adrenergic non cholinergic neurotransmission in the rat mesenteric arterial bed are of the A1 subtype. J Pharmacol Exp Ther 267 (1993) 1100-1104
20. Conti A., Monopoli A., Gamba M., Borea P.A., and Ongini E. Effects of selective A1 and A2 adenosine receptor agonists on cardiovascular tissues. Naunyn Schmiedeberg's Arch Pharmacol 348 (1993) 108-112
21. Rubino A., Ralevic V., and Burnstock G. Contribution of P1 (A2B subtype) and P2 purinoceptors to the control of vascular tone in the rat isolated mesenteric arterial bed. Br J Pharmacol 115 (1995) 648-652
22. Sollevi A. Cardiovascular effects of adenosine in man: possible clinical implications. Prog Neurobiol 27 (1986) 319-349
23. Shryock J.C., Snowdy S., Baraldi P.G., Cacciari B., Spalluto G., Monopoli A., Ongini E., Baker S.P., and Bellardinelli L. A2a adenosine receptor reserve for coronary vasodilation. Circulation 98 (1998) 711-718
24. Brignole M. Randomized clinical trials of neurally mediated syncope. J Cardiovasc Electrophysiol 14 (2003) S64-S69
25. Moore A., Close J.C., and Jackson S.H. A refractory case of vagal syncope treated with theophylline. Clin Auton Res 13 (2003) 293-294
26. Conlay L.A., Conant J.A., deBros F., and Wurtman R. Caffeine alters adenosine plasma levels. Nature 389 (1997) 136
27. Wu S.N., Linden J., Visentin S., Boykin M., and Belardinelli L. Enhanced sensitivity of heart cells to adenosine and up-regulation of receptor number after treatment of guinea pigs with theophylline. Circ Res 65 (1989) 1066-1077
28. Cassada C.D., Tribble C.G., Long S.M., Kaza A.K., Linden J., Rieger J.M., Rosin D., Kron I.L., and Kern J.A. Adenosine A2A agonist reduces paralysis after spinal cord ischemia: correlation with A2A receptor expression on motor neurons. Ann Thorac Surg 74 (2002) 846-849 discussion 849-850
29. Shinzato T., Miwa M., Nakai S., Morita H., Odani H., Inoue I., and Maeda K. Role of adenosine in dialysis-induced hypotension. J Am Soc Nephrol 4 (1994) 1987-1994
30. Pinto-Duarte A., Coelho J.E., Cunha R.A., Ribeiro J.A., and Sebastiao A.M. Adenosine A2A receptors control the extracellular levels of adenosine through modulation of nucleoside transporters activity in the rat hippocampus. J Neurochem 93 (2005) 595-604
31. Von Kugelgen I., Allgaier C., Schobert A., and Starke K. Co-release of noradrenaline and ATP from cultured sympathetic neurons. Neuroscience 61 (1994) 199-202
32. Pelleg A., and Burnstock G. Physiological importance of ATP release from nerve terminals and its degradation to adenosine in humans. Circulation 82 (1990) 2269-2272
33. Hashimoto M., Shinozuka K., Tanaka Y., Honda M., Ishida Y., Bjur R.A., Westfall D.P., Hattori K., and Masumura S. Source of ATP, ADP, AMP and adenosine released from isolated rat caudal artery exposed to noradrenaline. J Smooth Muscle Res 33 (1997) 127-133
34. Tank J., Baevski R.M., Fender A., Baevski A.R., Graves K.F., Ploewka K., and Weck M. Reference values of indices of spontaneous baroreceptor reflex sensitivity. Am J Hypertens 13 (2000) 268-275
35. Yasumasu T., Abe H., Oginosawa Y., Takahara K., and Nakashima Y. Assessment of cardiac baroreflex function during fixed atrioventricular pacing using baroreceptor-stroke volume reflex sensitivity. J Cardiovasc Electrophysiol 16 (2005) 727-731
36. Bauer A., Kantelhardt J.W., Barthel P., Schneider R., Makikallio T., Ulm K., Hnatkova K., Schomig A., Huikuri H., Bunde A., Malik M., and Schmidt G. Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study. Lancet 367 (2006) 1674-1681